Nuveen Asset Management, LLC Immunic, Inc. Transaction History

Nuveen Asset Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$3.13 - $12.25 $230,749 - $903,094	-73,722 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$9.54 - $14.26 $15,798 - $23,614	-1,656 Reduced 2.2%	73,722 $830,000
Q4 2021 Feb 14, 2022	SELL	$7.34 - $10.25 $41,162 - $57,482	-5,608 Reduced 6.92%	75,378 $638,000
Q3 2021 Nov 12, 2021	BUY	$8.05 - $13.29 $48,799 - $80,563	6,062 Added 8.09%	80,986 $763,000
Q2 2021 Aug 16, 2021	BUY	$11.76 - $16.85 $388,938 - $557,280	33,073 Added 79.03%	74,924 $919,000
Q1 2021 May 17, 2021	SELL	$14.21 - $25.3 $1.64 Million - $2.92 Million	-115,235 Reduced 73.36%	41,851 $667,000
Q4 2020 Feb 16, 2021	SELL	$14.8 - $20.37 $120,531 - $165,893	-8,144 Reduced 4.93%	157,086 $2.4 Million
Q3 2020 Nov 16, 2020	BUY	$11.74 - $22.0 $1.72 Million - $3.22 Million	146,181 Added 767.39%	165,230 $3.07 Million
Q2 2020 Aug 14, 2020	BUY	$5.67 - $15.86 $108,007 - $302,117	19,049 New	19,049 $231,000

56M

4.7K

311K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $36.1M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.